In this episode, we’re joined by Dr. Marc Hoffmann from The University of Kansas Cancer Center, to explore chronic lymphocytic leukemia (CLL)—what it is, how it’s treated today, and where research is headed. Dr. Hoffmann shares insights on treatment goals, side effect management, and the importance of shared decision making. We also touch on emerging therapies—including CAR T-cell therapy and bispecifics—and end with a message of hope for those navigating life after a CLL diagnosis.

Mentioned on this episode: 

• Chronic Lymphocytic Leukemia
• Shared Decision-Making Chronic Leukemias Interactive Program
• CAR T-cell therapy
• Allogeneic stem cell transplantation
• LLS Clinical Trial Support Center
• Financial support
• How Far Have We Come: Mantle Cell Lymphoma – Dr. Jacob Soumerai

Additional LLS Support Resources: 

• Free Nutrition Consultations
• Information Specialists 
• Free telephone/web patient programs 
• Free booklets 
• Young Adult Resources
• Support groups 
• Caregiver support 
• Caregiver Workbook
• Survivorship Workbook
• Advocacy and Public Policy
• LLS Community
• Mental Health Resources

Supported by AbbVie Inc., Medicines and Genentech, A Member of the Roche Group.

The post Partnering in Care: Chronic Lymphocytic Leukemia (CLL) first appeared on The Bloodline with LLS.